353 related articles for article (PubMed ID: 21087238)
1. Neuronox versus BOTOX for spastic equinus gait in children with cerebral palsy: a randomized, double-blinded, controlled multicentre clinical trial.
Kim K; Shin HI; Kwon BS; Kim SJ; Jung IY; Bang MS
Dev Med Child Neurol; 2011 Mar; 53(3):239-44. PubMed ID: 21087238
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group.
Koman LA; Mooney JF; Smith BP; Walker F; Leon JM
J Pediatr Orthop; 2000; 20(1):108-15. PubMed ID: 10641699
[TBL] [Abstract][Full Text] [Related]
3. [Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study].
Mousny M; Allington N
Rev Chir Orthop Reparatrice Appar Mot; 1999 May; 85(2):156-63. PubMed ID: 10392416
[TBL] [Abstract][Full Text] [Related]
4. [Botulinum toxin treatment in children].
Sätilä H; Vähäsarja V; Paavilainen P
Duodecim; 2011; 127(22):2417-24. PubMed ID: 22238919
[TBL] [Abstract][Full Text] [Related]
5. The effect of injections of botulinum toxin type A combined with casting on the equinus gait of children with cerebral palsy.
Hayek S; Gershon A; Wientroub S; Yizhar Z
J Bone Joint Surg Br; 2010 Aug; 92(8):1152-9. PubMed ID: 20675764
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of botulinum toxin therapy of spastic equinus in paediatric patients with cerebral palsy.
Manganotti P; Zaina F; Falso M; Milanese F; Fiaschi A
J Rehabil Med; 2007 Mar; 39(2):115-20. PubMed ID: 17351692
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type A injections for treatment of spastic equinus in cerebral palsy: a secondary analysis of factors predictive of favorable response.
Sätilä H; Huhtala H
Am J Phys Med Rehabil; 2010 Nov; 89(11):865-72. PubMed ID: 20736816
[TBL] [Abstract][Full Text] [Related]
8. Use of a dynamic foot pressure index to monitor the effects of treatment for equinus gait in children with cerebral palsy.
Bennett D; Walsh M; O'Sullivan R; Gallagher J; O'Brien T; Newman CJ
J Pediatr Orthop; 2007; 27(3):288-94. PubMed ID: 17414011
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A and dynamic equinus in children with cerebral palsy: new indication. Better than repeat casts.
Prescrire Int; 2001 Feb; 10(51):12-4. PubMed ID: 11503850
[TBL] [Abstract][Full Text] [Related]
10. Short-term effects of "botulinum toxin a" as treatment for children with cerebral palsy: kinematic and kinetic aspects at the ankle joint.
Galli M; Crivellini M; Santambrogio GC; Fazzi E; Motta F
Funct Neurol; 2001; 16(4):317-23. PubMed ID: 11853322
[TBL] [Abstract][Full Text] [Related]
11. Treating spastic equinus foot from cerebral palsy with botulinum toxin type A: what factors influence the results?: an analysis of 189 consecutive cases.
Pascual-Pascual SI; Pascual-Castroviejo I; Ruiz PJ
Am J Phys Med Rehabil; 2011 Jul; 90(7):554-63. PubMed ID: 21765274
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin and short-term electrical stimulation in the treatment of equinus in cerebral palsy.
Detrembleur C; Lejeune TM; Renders A; Van Den Bergh PY
Mov Disord; 2002 Jan; 17(1):162-9. PubMed ID: 11835456
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin a injection into calf muscles for treatment of spastic equinus in cerebral palsy: a controlled trial comparing sonography and electric stimulation-guided injection techniques: a preliminary report.
Kwon JY; Hwang JH; Kim JS
Am J Phys Med Rehabil; 2010 Apr; 89(4):279-86. PubMed ID: 20068435
[TBL] [Abstract][Full Text] [Related]
14. Kinematic and kinetic evaluation of the ankle after intramuscular injection of botulinum toxin A in children with cerebral palsy.
Zürcher AW; Molenaers G; Desloovere K; Fabry G
Acta Orthop Belg; 2001 Dec; 67(5):475-80. PubMed ID: 11822078
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type A for the treatment of the spastic equinus foot in cerebral palsy.
Cardoso ES; Rodrigues BM; Barroso M; Menezes CJ; Lucena RS; Nora DB; Melo A
Pediatr Neurol; 2006 Feb; 34(2):106-9. PubMed ID: 16458821
[TBL] [Abstract][Full Text] [Related]
16. Determinants of responsiveness to botulinum toxin, casting, and bracing in the treatment of spastic equinus in children with cerebral palsy.
Yap R; Majnemer A; Benaroch T; Cantin MA
Dev Med Child Neurol; 2010 Feb; 52(2):186-93. PubMed ID: 20412253
[TBL] [Abstract][Full Text] [Related]
17. Spread of botulinum neurotoxin type a at standard doses is inherent to the successful treatment of spastic equinus foot in cerebral palsy: short-term neurophysiological and clinical study.
Frasson E; Dall'ora E; Bordignon M; Brigo F; Tocco P; Primon D; Didonè G; Vicentini S; Fiaschi A; Bertolasi L
J Child Neurol; 2012 May; 27(5):587-93. PubMed ID: 22114218
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Efficacy and Side Effects of Oral Baclofen Versus Tizanidine Therapy with Adjuvant Botulinum Toxin Type A in Children With Cerebral Palsy and Spastic Equinus Foot Deformity.
Dai AI; Aksoy SN; Demiryürek AT
J Child Neurol; 2016 Feb; 31(2):184-9. PubMed ID: 25999301
[TBL] [Abstract][Full Text] [Related]
19. Use of botulinum toxin type A in children with cerebral palsy.
Nolan KW; Cole LL; Liptak GS
Phys Ther; 2006 Apr; 86(4):573-84. PubMed ID: 16579673
[No Abstract] [Full Text] [Related]
20. Assessment protocol for serial casting after botulinum toxin a injections to treat equinus gait.
Kelly B; MacKay-Lyons MJ; Berryman S; Hyndman J; Wood E
Pediatr Phys Ther; 2008; 20(3):233-41. PubMed ID: 18703960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]